Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual beta-cell function
Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: a systemic review and meta-analysis
And that's how dirty this game is
Consider consulting a registered dietitian for personalized guidance, especially if you have kidney disease or other conditions requiring dietary modifications
Dai W, Shu R, Yang F, Li B, Johnson HM, Yu S, et al
At the formulation level, this GLP-1 analog features a substitution at position 34, replacing lysine with arginine